{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:53:12Z","timestamp":1779144792039,"version":"3.51.4"},"reference-count":19,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJC"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4330\/wjc.v2.i4.98","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T00:17:38Z","timestamp":1272241058000},"page":"98","source":"Crossref","is-referenced-by-count":16,"title":["Impaired diastolic function in na\u00efve untreated human immunodeficiency virus infected patients"],"prefix":"10.4330","volume":"2","author":[{"given":"Ugo","family":"Oliviero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506-2512.","DOI":"10.1210\/jc.2006-2190"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003;348:702-710.","DOI":"10.1056\/NEJMoa022048"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Monsuez JJ, Charniot JC, Escaut L, Teicher E, Wyplosz B, Couzigou C, Vignat N, Vittecoq D. HIV-associated vascular diseases: structural and functional changes, clinical implications. Int J Cardiol 2009;133:293-306.","DOI":"10.1016\/j.ijcard.2008.11.113"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:1723-1735.","DOI":"10.1056\/NEJMoa062744"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Carr A. Cardiovascular risk factors in HIV-infected patients. J Acquir Immune Defic Syndr 2003;34 Suppl 1:S73-S78.","DOI":"10.1097\/00126334-200309011-00011"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Stein JH. Cardiovascular risks of antiretroviral therapy. N Engl J Med 2007;356:1773-1775.","DOI":"10.1056\/NEJMe078037"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001;104:257-262.","DOI":"10.1161\/01.CIR.104.3.257"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Sankatsing RR, Wit FW, Vogel M, de Groot E, Brinkman K, Rockstroh JK, Kastelein JJ, Stroes ES, Reiss P. Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors. Atherosclerosis 2009;202:589-595.","DOI":"10.1016\/j.atherosclerosis.2008.05.028"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Thöni GJ, Schuster I, Walther G, Nottin S, Vinet A, Boccara F, Mauboussin JM, Rouanet I, Edérhy S, Dauzat M. Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapies. AIDS 2008;22:2537-2540.","DOI":"10.1097\/QAD.0b013e328319806d"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Oliviero U, Bonadies G, Apuzzi V, Foggia M, Bosso G, Nappa S, Valvano A, Leonardi E, Borgia G, Castello G. Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis 2009;204:586-589.","DOI":"10.1016\/j.atherosclerosis.2008.10.012"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Qui\u00f1ones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-184.","DOI":"10.1067\/mje.2002.120202"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Salerno M, Oliviero U, Lettiero T, Guardasole V, Mattiacci DM, Saldamarco L, Capalbo D, Lucariello A, Saccà L, Cittadini A. Long-term cardiovascular effects of levothyroxine therapy in young adults with congenital hypothyroidism. J Clin Endocrinol Metab 2008;93:2486-2491.","DOI":"10.1210\/jc.2007-2315"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, Nagueh SF. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 2004;109:2432-2439.","DOI":"10.1161\/01.CIR.0000127882.58426.7A"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Schuster I, Thöni GJ, Edérhy S, Walther G, Nottin S, Vinet A, Boccara F, Khireddine M, Girard PM, Mauboussin JM. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol 2008;101:1213-1217.","DOI":"10.1016\/j.amjcard.2007.11.073"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Pozzan G, Pagliari C, Tuon FF, Takakura CF, Kauffman MR, Duarte MI. Diffuse-regressive alterations and apoptosis of myocytes: possible causes of myocardial dysfunction in HIV-related cardiomyopathy. Int J Cardiol 2009;132:90-95.","DOI":"10.1016\/j.ijcard.2007.10.057"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Monsuez JJ, Escaut L, Teicher E, Charniot JC, Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol 2007;120:150-157.","DOI":"10.1016\/j.ijcard.2006.11.143"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Kosmala W, Derzhko R, Przewlocka-Kosmala M, Orda A, Mazurek W. Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 2008;19:375-382.","DOI":"10.1097\/MCA.0b013e3282fc617c"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Hogg K, McMurray J. The treatment of heart failure with preserved ejection fraction (\"diastolic heart failure\"). Heart Fail Rev 2006;11:141-146.","DOI":"10.1007\/s10741-006-9488-6"}],"container-title":["World Journal of Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:23:23Z","timestamp":1559067803000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1949-8462\/full\/v2\/i4\/98.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.4330\/wjc.v2.i4.98","relation":{},"ISSN":["1949-8462"],"issn-type":[{"value":"1949-8462","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}